Your Article Summary
See Latest ArticlesNitazoxanide and Probiotics for the Treatment of Recurrent Clostridium difficile Infection in a Peritoneal Dialysis Patient
Southern Medical Journal, 07/02/09
Yangco BG et al. - A 58-year-old woman was admitted with hypotension, nausea and vomiting attributed to metronidazole therapy for CDI, her third CDI treatment regimen in 3 months. During her admission, the patient developed CDI and was started on a 6-week regimen of nitazoxanide and probiotics to assist in re-establishing the colonic flora. The regimen was well tolerated and the patient remained disease free at follow up, four months later.
Related Articles
The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2alpha Via Protein Kinase Activated by Double-Stranded RNA Activation
Gastroenterology, 10/29/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09
The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Characterization of enteroglial cells and denervation process in chagasic patients with and without megaesophagus
Human Pathology, 12/16/09
Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis
Gastrointestinal Endoscopy, 12/16/09
Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit
Scandinavian Journal of Immunology, 12/16/09